Celcuity stock crashed Wednesday after the biotech delayed the launch of its just-approved breast ca...
Why This Biotech Stock, With Its First FDA Approval, Just Crashed By Double Digits
Celcuity stock crashed Wednesday after the biotech delayed the launch of its just-approved breast cancer treatment until the third quarter.
Author: Investor's Business Daily
Read Original Article